The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Prenatal Testing & Newborn Screening Market Grow Between 2026 And 2030?
The prenatal testing & newborn screening market’s size has observed rapid expansion in recent years. It is projected to expand from $6.98 billion in 2025 to $7.84 billion by 2026, showing a compound annual growth rate (CAGR) of 12.3%. The growth witnessed during the historic period is attributable to the broadening of public health screening initiatives, a rise in institutional births, the availability of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.
The prenatal testing & newborn screening market is poised for significant expansion in the coming years. Projections indicate its value will reach $12.22 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 11.8%. This anticipated growth during the forecast period is primarily driven by several factors, including the increasing scope of national screening mandates, the growing embrace of digital diagnostic platforms, rising investments directed towards maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding application of AI-assisted diagnostics. Key trends expected over the forecast period encompass the increasing integration of prenatal and newborn screening programs, a rising utilization of combined screening and diagnostic technologies, the growing implementation of early intervention protocols, the expansion of automated screening workflows, and an enhanced focus on comprehensive population-wide screening initiatives.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
What Major Factors Are Driving The Prenatal Testing & Newborn Screening Market Forward?
The significant occurrence of genetic illnesses in infants has fueled the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic conditions, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a widespread genetic disorder impacting millions globally, is notably prevalent among populations with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. Illustratively, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine in February 2023 revealed that single-locus (Mendelian) genetic diseases accounted for 41% of infant fatalities. This elevated incidence of genetic conditions in babies has thus spurred the demand for the prenatal testing and newborn screening market.
What Are The Different Segment Types In The Prenatal Testing & Newborn Screening Market Segment Breakdown?
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End User: Hospitals, Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis
Which Trends Are Impacting The Progress Of The Prenatal Testing & Newborn Screening Market?
Companies operating within the prenatal testing & newborn screening market are concentrating on developing newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions, thereby facilitating prompt interventions and better health outcomes for newborns. A newborn screening point-of-care device is designed to deliver faster, more accessible, and cost-effective screening for newborns, supporting the seven standard newborn screening tests conducted globally. For instance, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is engineered to be low-cost, projected to be about one-fifth the price of existing solutions, which often range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to enhance access to critical health services for newborns, particularly in underserved regions.
Who Are The Well-Known Companies In The Prenatal Testing & Newborn Screening Market?
Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company
Get The Full Prenatal Testing & Newborn Screening Market Report:
Which Region Holds The Highest Market Share In The Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Prenatal Testing & Newborn Screening Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Next Generation Sequencing Market
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Protein Sequencing Market Report
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model